Artwork

Content provided by CNBC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CNBC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The Markets, Final Presidential Debate, FDA Approves First Treatment For COVID-19 And Intel Tumbles

43:03
 
Share
 

Manage episode 393101419 series 2534991
Content provided by CNBC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CNBC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Carl Quintanilla, Jim Cramer and David Faber explored a number of issues on Wall Street's radar: The second and final presidential debate of the 2020 election - including reaction to President Trump's vaccine timeline, Gilead shares rising after its

antiviral remdesivir became the first drug to receive FDA approval for treatment of COVID-19, and Intel shares tumbling after weakness in the chip maker's data center business impacted quarterly results.

Also in focus: Apple's new iPhone 12 hitting stores in China and what to expect from sales of the device in the U.S., plus the stock winners and losers to cap what has been a busy week on the earnings front.

  continue reading

1497 episodes

Artwork
iconShare
 
Manage episode 393101419 series 2534991
Content provided by CNBC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CNBC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Carl Quintanilla, Jim Cramer and David Faber explored a number of issues on Wall Street's radar: The second and final presidential debate of the 2020 election - including reaction to President Trump's vaccine timeline, Gilead shares rising after its

antiviral remdesivir became the first drug to receive FDA approval for treatment of COVID-19, and Intel shares tumbling after weakness in the chip maker's data center business impacted quarterly results.

Also in focus: Apple's new iPhone 12 hitting stores in China and what to expect from sales of the device in the U.S., plus the stock winners and losers to cap what has been a busy week on the earnings front.

  continue reading

1497 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide